tirzepatide tablets work Microdose free tablet Oral Tirzepatide Pill: FDA-Approved Options

This medication works by enhancing insulin secretion, suppressing glucagon release, and slowing gastric emptyingmechanisms that contribute to improved glycemic control and weight loss

Resistance training during treatment helps preserve muscle mass by maintaining the mechanical stimulus that signals the body to retain lean tissue even during caloric deficit

Important Safety Information: Gastrointestinal Effects are the predominant side effects according to the prescribing information: Nausea (12-24% of patients) typically mild to moderate and often diminishes over time Diarrhea (13-17% of patients) usually transient and manageable with dietary modifications Vomiting (6-10% of patients) more common at higher doses Constipation (5-11% of patients) may require increased fluid intake and fiber Abdominal pain and dyspepsia (5-10% of patients) generally self-limiting Decreased appetite an expected pharmacological effect that contributes to weight loss These gastrointestinal symptoms are dose-dependent and typically most pronounced during the first few weeks after starting treatment or increasing the dose

Patients with active eating disorders or conditions where further weight changes would be harmful should be carefully evaluated by their provider before initiating this therapy

Participants were encouraged to engage in at least 150 min of moderate-intensity physical activity per week (for example, brisk walking)